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Internal carotid artery (ICA) and vertebral artery (VA) aneurysms are most frequent 
aneurysmatic lesions. Especially intracranial aneurysms are pathologic focal dilatations of 
the cerebrovasculature that are prone to rupture. These vascular abnormalities are classified 
by presumed pathogenesis. Saccular, berry, or congenital aneurysms constitute 90% of all 
cerebral aneurysms and are located at the major branch points of large arteries. 
Dolichoectatic, fusiform, or arteriosclerotic aneurysms account for 7% of all cerebral 
aneurysms. Infectious or mycotic aneurysms are situated peripherally and comprise 0.5% of 
all cerebral aneurysms. Other peripheral lesions include neoplastic aneurysms, rare sequelae 
of embolized tumor fragments, and traumatic aneurysms. Saccular intracranial aneurysms 
are situated in the anterior circulation in 85-95% of cases, whereas dolichoectatic aneurysms 
predominantly the vertebrobasilar system. Multiple saccular aneurysms are noted in 20-30% 
of patients with cerebral aneurysms. Aneurysmal rupture can result most often in 
subarachnoid hemorrhage, but may also present as intraparenchymal, intraventricular, or 
subdural hemorrhage. Giant saccular aneurysms, defined as greater than 25 mm in 
diameter, may cause SAH, but these lesions more frequently produce mass effect and may 
result in distal thromboembolism.  
On the other hand, extracranial internal carotid and vertebral artery aneurysms usually may 
present with cerebral embolism, transient ischemic attack, cerebrovascular insufficiency, 
continued enlargement with compression syndrome, vessel occlusion or hemorrhage. 
Aneurysms may be also often asymptomatic until the time of rupture. In the past, most of 
these aneurysms were treated surgically. Surgery, however, is often difficult because of the 
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location and the damaged arterial wall and may result in sacrifice of the internal carotid or 
vertebral artery. Vertebral artery (VA) aneurysms constitute 0.5 to 3% of intracranial 
aneurysms and 20% of posterior circulation aneurysms [1]. The causes of aneurysms are 
multiple and may occur following trauma, mycotic infection, as a result of atherosclerosis, 
tumor invasion or radiation necrosis or iatrogenic. Among these, dysplastic lesions 
appeared to be the main cause of extracranial internal carotid artery aneurysms, associated 
or not with spontaneous dissection. VA aneurysms include VA-PICA (posterior inferior 
cerebellar artery) aneurysms, vertebro-basilar junction aneurysms, distal PICA aneurysms 
and those aneurysms located along the distal VA. Dissecting aneurysms of the intradural 
vertebral arteries often present with subarachnoid haemorrhage. A second episode of 
bleeding (rebleeding) is common and deadly. Rebleeding rates were estimated at 71% of 
cases with subsequent re-rupture of the aneurysms in 57% [2]. Ruptured posterior 
circulation aneurysms are technically difficult to expose and clip and their management and 
surgical outcomes are poorer as compared to anterior circulation aneurysms [3]. They often 
need expertise with various skull base approaches to improve the exposure, to minimize 
brain retraction and to achieve better outcome. Certain subset of posterior circulation 
aneurysms are considered at even higher risk for surgery due to their location and the size, 
prompting recourse to other modalities of therapy. 
1.2. Diagnostic imaging 
Early diagnosis and evaluation of anatomical characteristics of the internal carotid and 
vertebral artery aneurysms are essential in terms of surgical or endovascular treatment 
planning.  
Ultrasound imaging is initially useful in the diagnostic process for cases with suspicion for 
extracranial internal carotid artery aneurysm palpable pulsatile mass at neck region. It serves 
for determination of the size and extension of the aneurysm. Although ultrasound is a 
valuable diagnostic tool for definition of anechoic structure and pulsation of the aneurysm, it 
may become insufficient in defining thrombosed aneurysm, relation of the aneurysm with its 
neighboring structures. Duplex ultrasound scanning is the most simple investigation in the 
detection of vertebral and extracranial internal carotid artery aneurysms, but this may fail if 
the lesion is located high, especially if the patient has a short neck or when the examination is 
focused on stenosis diagnostic and if the size of the aneurysm is small.  
In diagnosing and characterizing the aneurysms, DSA is still the gold standard imaging 
method. But, since DSA is an invasive method, persistant neurological complications can 
develop and that´s why nowadays it is mostly used just for endovascular treatment. DSA 
most often provides the diagnosis of the lesion, specifies the localization, and detects any 
associated lesion, stenosis, or wall irregularities inducing a carotid dysplasia. The 
disadvantage of DSA is showing only the patent lumen and the risk of complications 
associated with invasive catheterization. Therefore, recently noninvasive or minimally 
invasive methods, such as CT angiography and MR angiography are more popular to detect 
and demonstrate the aneurysms.  
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Contrast enhanced CT scanning with three-dimensional reconstructions allows analysis of 
the aneurysm and assesses the possible existence of a false lumen channel, representing the 
existence of a previous dysplastic or traumatic dissection. Analysis of the slices at the 
osseous window allows the assessment of the distance between the upper limit of the 
aneurysm and the temporal bone. Currently, contrast enhanced CT scanning with 
reconstruction is the most sophisticated examination available and gives the most 
information. CT angiography (CTA) has advantages such as easy and rapid applicability, 
being a minimally invasive method, having no manifest complication besides contrast 
medium allergy, capability of rotating the images 360° [4]. The most important advantage of 
CT angiography is its capability of evaluating images on preferred planes and angles on the 
screen. Therefore, superimposed vessel images in DSA making it hard to evaluate are easily 
evaluated with CT angiography. Moreover, capability of rotating the CT angiographic 
images on preferred planes and angles helps the surgeon or interventional radiologist in 
orientation to approach the aneurysm and in the treatment planning (Figure 1). Contrary, 
CT angiography has some limitations. Differentiation of small aneurysms from neighboring 
bones is not possible each time and CT angiography is not capable of showing the collateral 
circulation as seen in DSA [5]. Both arteries and veins are visible in CT angiography and 
sometimes it is not easy to differentiate either of them. CT angiography has also limitations 
in the postoperative management of aneuryms, especially in patients receiving coil 
embolisation because of coil artefacts. 
 
Figure 1. Maximum intensity projection (A) and virtual rendering technique (B) reconstructions of 
aneurysm of left intradural part of vertebral artery.  
Magnetic resonance angiography (MRA) is a non-invasive method that can visualize 
vascular structures without a need for contrast medium injection or radiation. MRA can 
manifest the thrombosed portions of aneurysms, residual lumina and flow characteristics. 
MRA is particularly useful in suspicion of carotid artery dissection due to its characteristic 
of detecting the old blood in dissected area. MRA and CT angiography mainly replaced the 
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conventional angiography. Promiment factors that emphasize superiority of MRA to 
arteriography are that it excludes the risk of stroke associated with angiography and also 
possible access site complications and it gives information about the surrounding tissues. 
MRA also provides reconstruction and rotation of images of intracranial circulation and 
evaluation of collateral circulation better than angiography.  
1.3. Endovascular treatment 
The current treatment options include surgical treatment and endovascular treatment, but 
these are not without significant problems [6]. For instance, a randomised, multicentre trial 
compared the safety and efficacy of endovascular coiling with standard neurosurgical 
clipping for intracranial aneurysms found that the outcome in terms of survival free of 
disability at 1 year is significantly better with endovascular coiling [7]. In addition, 
neurosurgery is associated with significantly longer length of stay and significantly higher 
total hospital charges [8]. Surgical treatment of extracranial internal carotid artery 
aneurysms located near skull base is technically challenging with high morbidity and 
mortality rates. In addition, surgical approach often requires an extended cervicotomy, 
mandibular subluxation, resection of the styloid process, and sometimes a transection of the 
external auditory canal with resection of the mastoid and vaginal process of the styloid bone 
to expose the first vertical intrapetrous segment of the ICA and risk of cranial nerve injury. 
Over the past decades, with advances in technologies, endovascular therapy is becoming the 
first-line treatment in the treatment of internal carotid and vertebral artery aneurysms and 
offers a minimally invasive alternative to open surgery. 
Endovascular treatment options includes covered stent placement, flow diverting device 
(FDD) placement, parent vessel sacrifice with detachable  balloons and coils, coil 
embolisation of the aneurysm with or without a stent placement. Endovascular techniques 
are usually performed via a femoral access route with placement of either covered stent, 
FDD or stent extending from the normal artery site to the distal vessel beyond the 
aneurysm. Despite the trend toward endovascular treatment the rate of recurrence and 
complications can be high.  
This article describes current possibilities in endovascular treatment of vertebral and 
internal carotid artery aneurysms, with special focus on covered stents with our experience 
and description of used techniques in the treatment of internal carotid and vertebral artery 
aneurysms. 
2. Body 
2.1. CASE 1 
A 52-year-old female with a pulsatile palpable mass in the left retromandibular space was 
referred to our hospital. Computed tomography angiography revealed a giant false 
aneurysm of the left cervical segment of the internal carotid artery (ICA) that was probably 
due to arterial injury caused by an elongated Styloid process. CTA revealed significant 
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elongation and tortuosity of the left and right proximal ICA and a large supra-ophthalmic 
aneurysm of the right ICA (Figure 2).  
 
Figure 2. CTA finding of a styloid process causing a false aneurysm of the left ICA, elongation of both 
proximal parts of the ICA and a large aneurysm of the supra-ophthalmic part of the right ICA (A, B).  
A four-step, multidisciplinary therapeutic plan combining surgical and endovascular 
modalities was selected: (i) resection and straightening of proximal tortuosity of the right 
ICA; (ii) endovascular coiling of intracranial aneurysms (Figure 3); (iii) resection and 
straightening of the proximal left ICA; and (iv) endovascular treatment of the false 
aneurysms in the left retromandibular space using covered stent.  
 
Figure 3. DSA before coiling of the aneurysm of the supra-ophthalmic part of the right ICA (A) and 
after endovascular treatment (B).  
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Before implantation of the pericardium civered stent (PCS), the patient was given 100 mg 
aspirin and 300 mg clopidogrel. Right femoral access was used and digital subtraction 
angiography (DSA) of the left carotid artery confirmed the findings of the CTA (Figure 4A, 
4B). A 6-F guiding catheter (Guider Softip™ XF, Boston Scientific Corp., Fremont, CA, USA) 
was advanced in the distal part of the common carotid artery (CCA). A 0.014 guidewire 
(Synchro, Boston Scientific Corp., Fremont, CA, USA) was then passed distal to the neck of the 
aneurysm. The length of the aneurysm neck necessitated two PCS, and resulted in complete 
exclusion of the aneurysm demonstrated on post-procedure angiography (Figure 4C). 
 
Figure 4. CTA (A) and DSA (B) of a giant false aneurysm of the cervical segment of the left ICA and 
post-procedure angiography after placement of a covered stent (C).  
2.2. CASE 2 
A 44-year-old female was referred to our hospital after suffering a subarachnoid 
hemorrhage. Coiling of a small aneurysm of the communicating segment of the left ICA had 
been done.  A giant (20  18 mm), large-neck aneurysm was discovered on CTA at the 
intradural fourth segment of the left vertebral artery (VA) proximal to the posterior inferior 
cerebellar artery (PICA). Endovascular treatment was considered to be first-line treatment 
for this VA aneurysm. The patient received 100 mg aspirin and 75 mg clopidogrel for 3 days 
before the procedure. Right femoral access was used and a 6-F guiding catheter (Neuron, 
Penumbra Inc, San Leandro, California, USA) advanced to the V3 segment of the left VA. 
DSA showed a giant, large-neck aneurysm of the V4 segment of the VA (Figure 5A). After 
passage of a 0.014 guidewire (Synchro, Boston Scientific Corp., Fremont, CA, USA) distal to 
the aneurysm neck, a 4  27 mm PCS was deployed and inflated to 12 atm. The aneurysm 
was completely excluded and this was demonstrated at control angiography (Figure 5B). 
Follow-up CTA at 3 months demonstrated complete exclusion and shrinkage of the 
aneurysm to 18  16 mm (Figure 6). 
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Figure 5. Preoperative DSA of a giant aneurysm of the V4 segment of the left VA (A) and DSA after 
placement of a covered stent with no filling of the aneurysm (B).  
 
Figure 6. Three-month follow-up CTA showing aneurysm exclusion, a patent covered stent with no 
intimal hyperplasia, and aneurysm shrinkage. 
2.3. CASE 3 
An 85-year-old female was admitted to our hospital for endovascular therapy of a 
symptomatic large-neck aneurysm of the cervical segment of the ICA subsequent to a stroke in 
the left middle cerebral artery (MCA). The patient was pre-medicated with 100 mg aspirin and 
75 mg clopidogrel for 3 days before the procedure. Endovascular treatment was undertaken 
after gaining access via the femoral artery and placement of a 6-F guiding sheath (Guider 
Softip™ XF, Boston Scientific Corp., Fremont, CA, USA) in the CCA. DSA confirmed the CTA 
findings of an aneurysm of the cervical segment of the ICA (Figure 7A, 7B). A 0.014 guidewire 
(Synchro, Boston Scientific Corp., Fremont, CA, USA) was passed distal to the aneurysm and a 
PCS (4  27 mm) advanced over the wire and placed in the optimal position. The balloon was 
slowly inflated to 10 atm and the PCS successfully deployed. Control DSA confirmed complete 




Figure 7. CTA (A) and DSA (B) before endovascular treatment of an aneurysm of the left cervical 
segment of the ICA and final angiogram after implantation of a covered stent (C). 
2.4. CASE 4 
An 55-year-old male was admitted to our centre for endovascular treatment of a 
symptomatic dissecting aneurysm of the cervical segment of the ICA subsequent to a stroke. 
The patient was pre-medicated with 100 mg aspirin and 75 mg clopidogrel for 3 days before 
the endovascular procedure. Endovascular treatment was performed after gaining access via 
the right femoral artery and placement of a 6-F guiding sheath (Guider Softip™ XF, Boston 
Scientific Corp., Fremont, CA, USA) in the CCA. DSA confirmed the CTA findings of an 
aneurysm of the cervical segment of the ICA (Figure 8A). A 0.014 guidewire (Synchro, 
Boston Scientific Corp., Fremont, CA, USA) was passed distal to the aneurysm and a 
5x26mm Jostent Graftmaster (Abbott Vascular, Abbott Park, Ill, USA) advanced over the 
wire and successfully deployed after balloon inflation. Control DSA confirmed exclusion of 
the aneurysm with patent ICA (Figure 8B). 
 
Figure 8. DSA before (A) endovascular treatment of an aneurysm of the left cervical segment of the ICA 
and angiogram after endovascular treatment with implantation of a covered stent (B). 
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2.5. CASE 5 
A 44-year-old female was referred to our hospital for treatment of an asymptomatic 
fusiform aneurysm at the intradural fourth segment of the right vertebral artery. 
Endovascular treatment was considered to be first-line treatment for this VA aneurysm. The 
patient received 100 mg aspirin and 75 mg clopidogrel for 3 days before the procedure. Left 
femoral access was used and a 6-F guiding catheter (Neuron, Penumbra Inc, San Leandro, 
California, USA) advanced to the V3 segment of the right VA. DSA confirmed fusiform 
aneurysm of the V4 segment of the VA (Figure 9A). After passage of a 0.014 guidewire 
(Synchro, Boston Scientific Corp., Fremont, CA, USA) distal to the aneurysm neck, a flow 
diverting device Silk ((Balt, Montmorency, France) was deployed. The aneurysm was 
excluded and this was demonstrated at control angiography with no filling of the aneurysm 
(Figure 9B).  
 
Figure 9. DSA before (A) endovascular therapy of an aneurysm of the intradural segment of right 
vertebral artery and angiogram after implantation of flow diverting device (B). 
3. Discussion 
Different endovascular techniques have been used in the treatment of vertebral and internal 
carotid artery aneurysms. These include covered stent placement, flow diverting device 
(FDD) placement, parent vessel occlusion with detachable  balloons or coils, coil 
embolisation of the aneurysm with or without a stent placement. 
3.1. Covered stents 
In the past decade, covered stent placement has been proved to be effective for managing 
arteriovenous fistulas, aneurysms, and aortic dissections. Covered stents consist of a 
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synthetic material that either covers or is attached to a metallic stent to create a graft 
endoprosthesis. There are two different types of stent-deployment system - balloon-
expandable or self-expanding. Balloon-expandable system represent Jostent Graftmaster 
(Abbott Laboratories, Abbott Park, Ill) and iCast (Atrium Medical, Hudson, NH), self-
expanding covered stents are Fluency stent (Bard Peripheral Vascular, Tempe, Ariz), GORE 
VIABAHN (W.L. Gore & Assoc, Newark, Del), Wallgraft (Boston Scientific, MA) and Willis 
covered stent (MicroPort, Shanghai, China). Compared with aneurysm coil embolization, a 
covered stent has the following advantages: (1) a relatively simple and rapid performance; 
(2) a low risk of procedural-related rupture or rebleeding; (3) no coil herniation, delayed 
migration, and coil loop protrusion; (4) disappearance or reduction of mass effects in large 
or giant aneurysms; and (e) no aneurysm recanalization and recurrence. 
The Jostent graft is a composite stent with an ultrathin layer of expandable PTFE 
sandwiched between two stainless steel stents. It is balloon-expandable, covered-tube stent 
with radial strength. Jostent has been used for aneurysms up to the ophthalmic artery or up 
to the vertebrobasilar junction [9,10]. The Graftmaster has also been used for carotido-
cavernous fistulas and dissections [11]. Bergeron et al. recently published a series of six 
patients with EICA in which stent-grafts were used. They had no adverse event 
perioperatively and the long follow-up revealed patency of all grafts without sign of in-stent 
stenosis [12]. Chan et al. also reported two cases of successful endovascular treatment of 
distal internal carotid aneurysms using Jostent, with both patients remaining symptom-free 
at 1 year and no signs of graft restenosis [13]. Th disadvantage of Jostent is, that it might 
cause intimal damage at the stent edges as a result of irritation from vessel motion or 
anatomic distortion and also requires a relatively straight delivery path and is not well 
suited for use in very tortuous vessels. 
The Willis covered stent is specifically designed for use in the intracranial vasculature and 
consists of 3 parts: a bare stent, an expandable polytetrafluoroethylene (ePTFE) membrane, 
and a balloon catheter. The bare stent was constructed from a strand of cobalt chromium 
super alloy wire, which was 0.06mm in diameter. The ePTFE membrane, which was in a 
tubular configuration with a thickness of 30 to 50μm is glued along the length of the stent 
struts with use of organic agglomerate. To facilitate the membrane gluing along the stent, 
the diameter of tubular membrane is generally 0.05mm, which is wider than that of the 
inflated stent. To prevent the balloon from scaling the inner wall of the stent on withdrawal, 
the balloon is made into 5 valvae, instead of the commonly used 3 valvae. The whole body 
of the stent is radiopaque under fluoroscopy to facilitate precise placement of the stent. The 
stent can be manufactured in any diameter from 3 to 5mm and in any length from 7 to 15 
mm . The stent is mounted on a deflated balloon catheter with an outside diameter of 3.8F. 
Li at. al. performed successfull endovascular treatment of pseudoaneurysms of cranial 
internal carotid artery in 8 patients without procedural-related complications, and all of the 
stents were easily navigated to the targeted lesions. Complete resolution of the 
pseudoaneurysm was observed in 6 patients immediately after the procedure, and a 
minimal endoleak into the aneurysm persisted in 2 patients. No morbidity or mortality and 
no technical adverse event occurred. A follow-up angiogram confirmed complete 
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reconstruction of the internal carotid artery, with no recurrent aneurysmal filling and no 
occurrence of stenosis in the area of the stent [14]. The efficacy of the Willis covered stent in 
the treatment of traumatic pseudoaneurysms of the internal carotid artery was evaluated in 
13 patients with 14 delayed pseudoaneurysms with succesfull covered stent placement in all 
14 pseudoaneurysms. The initial angiographic results showed complete exclusion in 9 
patients with 10 aneurysms and incomplete exclusion in 4 patients. The angiographic mean 
follow-up 15 months findings exhibited a complete exclusion in 12 patients with 13 
aneurysms and an incomplete exclusion in 1 patient and maintained patency of the ICA in 
all patients with no procedure-related complications or deaths occurred during follow-up  
[15]. In another study, the navigation and deployment of the Willis covered stents were 
successful in 97.6% (41 of 42) of the patients with most of the aneurysms located at the C5 
through C7 segment. Although some complications occurred, the 93.5% (29 of 31 
aneurysms) final complete occlusion rate with no recanalization during follow-up addressed 
the effectiveness of the Willis covered stent for managing DICA aneurysms. In addition, 
endoleak occurred in 21.9% (7 of 32) of the patients owing to the tortuous segment of C5 
through C7, but it could not been eliminated by means of postprocedural dilation and 
additional stent implantation [16]. 
The Wallgraft consists of a PET (Dacron; E.I. duPont de Nemours and Co., Wilmington, DE) 
covered self-expanding cobalt super alloy stent. Wallgraft was utilized in 4 cases of inernal 
carotid artery trauma or disease leading to contained rupture or pseudoaneurysm formation. 
During a mean 16-month follow-up (range 6–24), duplex ultrasound and CT scanning found 
no evidence of restenosis, occlusion, or persistent perfusion of the pseudoaneurysm, which 
was noted to decrease in all cases [17]. Wallgraft  was also used in the treatment of tandem 
aneurysms of the extracranial internal carotid artery near the skull base with successfully 
exclusion with deployment of a single Wallgraft across both lesions with no complications 
encountered. At 2-year follow-up, the patient is doing well, without any sign of aneurysm 
reperfusion [18]. The Wallgraft has several disadvantages. First, PET is immunogenic which 
animal studies suggest, increases the rate of vessel thrombosis [19]. Second, the Wallgraft 
delivery system requires a 9-French arterial sheath in the carotid and vertebral arteries, which 
may increase the risk of pseudoaneurysms or groin hematomas at the femoral puncture site. 
Finally, the PET covering is initially porous until a clot forms to seal the fabric.  
Viabahn endograft is a PTFE covered nitinol stent with extreme flexibility and 
conformability to vessel configuration. Covered stents have also shown better closure and 
shorter procedure time in clinical investigations [20]. Current published evidence of the use 
of covered stent is limited to stents covered with polytetrafluoroethylene (PTFE) [21]. 
Synthetic materials are used in biological settings with limited success. Studies have shown 
that polyester covered stent graft with 50% re-stenosis and e-PTFE covered stent with 24% 
re-stenosis in a sheep iliac model [22]. It has also been shown that PTFE retards 
endothelization and that Dacron is prone to infection, due to adherence to and survival of 
bacteria on its rough surface [23]. Baldi et al. in their three cases had no periprocedural 
complications and all three PTFE Viabahn endografts were patent at 9 month follow-up 
without evidence of intimal hyperplasia [24].  
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A novel CE marked coronary stent covered with pericardium (Aneugraft: ITGI Medical 
limited, Or Akiva, Israel) is available, which so far shows promising clinical results. The 
pericardium covered stent (PCS) is a percutaneous implantable device consisting of a 316L 
stainless steel stent covered by a 100μ thick equine pericardium cylinder which makes this 
device flexible and trackable. It is available in diameters of 2.5mm, 3.0mm, 3.5mm, and 
4.0mm, and lengths of 13, 18, 23 and 27mm. The stent is mounted on a balloon catheter. 
Gluteraldehyde treated pericardium has been widely used for many years due to its 
desirable features such as low immunogenicity and durability [25-27]. It has been shown 
that there is significantly less inflammatory cytokine, significantly less antibody response 
and inflammatory response compared to un-crosslinked decellularized pericardium [28]. It 
is now recognized that mammalian extracellular matrix represents an excellent scaffold 
material suitable for many therapeutic applications [29]. In Neurosurgery, serous sheets are 
used as dural substitute. An investigation involving 200 patients undergoing a surgical 
procedure with the application of horse pericardium as a dural prosthesis found that they 
are free from antigenic effects and do not produce any toxic catabolites [30]. The 
pericardium proved to be resistant to surgical suture, impermeable to cerebrospinal fluid, 
transparent and does not cause any clinical evidence or radiological artifacts. Pericardium 
has also shown decreased intraoperative suture line bleeding compared to Dacron [31]. The 
PCS has shown to be safe and effective in 2 registries [32], and there is also published 
evidence attesting to this in other indications [33-36].  
There are several disadvantages regarding the use of covered stents in the cranial and 
extracranial vasculature. First, more clinical trials are required to determine the long-term 
outcomes. Second, the covered stents may not be flexible and conformable enough to 
navigate entirely through the extremely tortuous ICA and to fully conform to the 
configuration of the tortuous targeted arteries. Third, the possibility of a closure of the side 
branches stemming from the covered segment of the artery might occur after the stent 
placement. Therefore, balloon occlusion tests and angiography examinations from multiple 
projections should be routinely performed to avoid coverage of the side branches. In 
addition, in-stent restenosis might occur in patients who are not following the regular 
anticoagulation medication regimen after stent placement. 
3.2. FDD 
Flow diversion is a new approach to the endovascular treatment of intracranial aneurysms 
which uses a high density mesh stent to induce sac thrombosis. These devices have been 
designed for the treatment of complex shaped and large size aneurysms. Flow diversion 
aims to cure aneurysms by endovascular reconstruction of the parent vessel, without even 
performing endosaccular embolisation. The primary intent of a flow diversion device (as 
opposed to a stent) is to optimally alter the flow exchange between the parent artery and the 
aneurysm so as to promote complete thrombosis of the sac as rapidly as possible while 
eliciting minimal neointimal hyperplasia. The principal goal of the flow divertor is 
placement in the parent artery in order to reconstruct the vessel wall [37]. The concept of 
flow diversion appears promising in challenging lesions, including fusiform and/or giant 
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aneurysms. However, this stent presents major limitations: (a) the aneurysm occlusion 
process is unpredictable; (b) an associated complication rate much higher than those 
previously reported with conventional treatments (coiling, balloon- or stent-assisted coiling, 
parent artery occlusion, clipping); and (c) a high rate of significant parent artery stenosis. 
In contrast to an ideal stent, an ideal flow diversion device has low porosity and high pore 
density values optimized to promote intraaneurysmal thrombosis while maintaining 
patency of the parent vessel and side branches. Moreover, lower radial forces are required of 
this device as compared to a stent, which facilitates the optimization of other device 
characteristics such as longitudinal flexibility, trackability, and conformability. Recognition 
of the potential for aneurysm treatment by flow diversion is evidenced by the recent 
development of these devices by various groups.The major complications with flow 
divertors have been found to be perforator artery stroke, aneurysm re-rupture, and in-stent 
stenosis and thrombosis [38,39].  
The Pipeline stent (EV3, Irvine, Calif) is the first released flow-diverter stent and it has been 
evaluated in some series [40,41]. These authors showed that the Pipeline stent represents a 
safe, durable, and curative treatment of selected wide-necked, large, and giant aneurysms. 
The Pipeline stent has been used for the treatment of two male patients transferred after 
acute SAH and dissecting aneurysm on the V4 segment of the dominant vertebral artery 
with 3 Pipeline stents deployed in each vertebral artery. One dissecting aneurysm was 
excluded immediately after 3 stents and one patient had complete exclusion demonstrated 
at the 48 hour control. No morbidity directly related to the procedure was observed and no 
recanalization and no re-bleeding occurred during the 3 months follow-up [42].  In the 
recent publication, Yeung et al. demonstrated favourable long-term clinical and 
angiographic outcomes of FDD use and the ability to maintain parent artery and side branch 
patency for the endovascular treatment of unruptured dissecting intracranial vertebral 
aneurysms. In their series, total of 4 aneurysms were successfully obliterated by using flow-
diverting devices alone, two devices were deployed in a telescoping fashion in each of 2 
aneurysms, whereas only 1 device was inserted in each of the other 2 aneurysms with no 
periprocedural complications. No patient showed any angiographic evidence of recurrence, 
in-stent thrombosis, or side-branch occlusion in angiographic reassessment at a mean of 22 
months after treatment (range 18-24 months) [43]. 
The other available flow-diverter device is the Silk stent (Balt, Montmorency, France) and 
little information is available concerning its use [44-46]. By the use of telescopic catheters, 
the Silk stent may be placed in most patients. Silk opening and wall apposition frequently 
require pushing back the delivery catheter. This is particularly mandatory within curved 
vessel such as the ICA siphon. Because of its low radial force, the Silk stent must be placed 
with great caution if the vessel shows a stenotic portion because vessel occlusion may occur. 
Moreover, careful size and length selection is mandatory because stent shortening and 
migration may happen. For all these reasons, Silk stent placement is more difficult than 
nonflow-diverter self-expandable stent.  
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3.3. Parent vessel occlusion 
One of the treatment options available for patients with internal carotid or vertebral artery 
aneurysms is parent vessel occlusion, either surgical or endovascular. The goal of parent 
vessel occlusion for the treatment of fusiform aneurysms is intra-aneurysmal thrombosis 
and involution of the aneurysm. Endovascular occlusion can be achieved with detachable 
balloons or coils or with a combination of the two. Studies reporting patient outcomes after 
parent vessel occlusion for treatment of fusiform aneurysms of the vertebrobasilar 
circulation have been limited. A few series have reported the results of parent vessel 
occlusion in the posterior circulation, although not exclusively for intracranial fusiform 
aneurysms. In one study the long-term outcomes for 21 patients with unclippable posterior 
circulation aneurysms treated with either unilateral or bilateral parent vessel occlusion of 
the vertebral artery, with a mean follow-up of 2 years (range, 6 months to 6 years) were 
examined [47]. Six of the patients had fusiform aneurysms, and the remaining 5 had 
aneurysms that were of saccular morphology. All occlusions in this series were performed 
by using latex balloons. Thirteen (61.9%) of 21 patients achieved good outcomes, including 
angiographic cure and clinical improvement. Twenty-eight and six-tenths percent of the 
patients had partial thrombosis of their aneurysm. One death and one treatment failure 
occurred.  
Occlusion of the internal carotid artery may lead to severe cerebrovascular events and 
therefore a balloon occlusion test should be performed in advance; if a temporary occlusion 
test is successful, trapping or parent artery occlusion is an option. However, it has been 
shown that 5–22% of patients passing the balloon occlusion test develop ischemic 
complications, including cerebral infarct, while some reports have revealed cerebral 
aneurysm formation after permanent carotid occlusion [48,49]. The placement of detachable 
balloons in the ICA above and below the false aneurysm can completely eliminate blood 
flow. Disadvantages with this endovascular approach include the possibility of embolic 
cerebrovascular accidents. If the patient cannot tolerate the occlusion test, an extracranial-to-
intracranial bypass should be contemplated. 
3.4. Coil embolisation and stent placement 
Another treatment option in the management of aneurysms represents stent placement with 
or without coil embolisation and coil embolisation without stent placement. Findings of 
experimental studies have shown that a metallic stent, bridging the aneurysmal neck, may 
alter the flow pattern within the aneurysm, promoting thrombus formation and aneurysmal 
occlusion [50,51]. Although immediate aneurysmal occlusion can be seen after single stent 
placement for treatment of extracranial pseudoaneurysms, in some cases, 3–6 months or 
longer may pass before occlusion occurs. To achieve faster complete aneurysmal occlusion, 
the combination of stents and detachable coils has been suggested for extracranial, as well as 
intracranial aneurysms [2,52,53] and the combination is currently considered an alternative 
to single stent placement or other techniques such as the remodeling technique or parent 
vessel occlusion. Lanzino et al [52] reported 10 cases managed with stent-supported coil 
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embolization; they achieved aneurysmal occlusion of more than 90% in eight patients. In 
four of these patients, treated with stent placement only, no evidence of intraaneurysmal 
thrombosis was found either immediately or during follow-up studies performed 48 hours 
(two patients), 4 days (one patient), and 3 months (one patient) after treatment. Phatouros et 
al [2] reported a series of seven patients with fusiform aneurysms, wide-neck aneurysms, or 
pseudoaneurysms who underwent stent-supported coil embolization; technical success was 
achieved in six. In one patient, a coil became entangled with the stent, resulting in partial 
coil delivery into the parent artery with no neurologic sequelae. 
However, certain limitations, may be encountered when stents are used in conjunction with 
coils. In some cases, a microcatheter can be navigated through the stent interstices only with 
difficulty. Packing of the aneurysm sac can be inaccurate because of the density of platinum 
detachable coils. Multiple projections with big amount of used contrast medium may 
become necessary, particularly with fusiform aneurysms, and in some cases, complete 
packing of the aneurysm cannot be achieved. Coil loops may become entangled with the 
stent struts and unravel during attempts to retrieve them, leading to the risk of moving the 
stent or leaving coils within the parent artery. A report by Phatouros et al [2] shows the 
successful use of stent-supported coil embolization in the treatment of fusiform and wide 
neck aneurysms. The stent mesh allows for attenuated packing of the aneurysm with less 
concern for herniation of coils into the parent artery. Phatouros et al reported technical 
success in six of the seven patients treated, with 0% 30-day periprocedural morbidity and 
mortality. After a mean follow-up of 14.5 months, all the patients treated with stent-
supported coil embolization were at their neurologic baseline or had improved. The authors 
acknowledged the current limitations of this therapy, including the concern for occluding 
small but important perforators with the struts of the stent. Kurata et al. published their 
findings in a series of 24 ruptured dissecting vertebral artery aneurysms. Endosaccular 
embolisation was performed within 4 days of onset of symptoms with no experienced 
complications with coil embolisation. Radiologic investigation showed complete occlusion 
of the dissection and patency of the unaffected artery at a mean follow-up of 9 months [54]. 
The use of double stent placement for complete exclusion of wide-neck aneurysms has been 
reported in only a single case to date [55], however double stent placement may be a 
relatively simple technique to more effectively change intraaneurysmal flow and achieve 
subsequent thrombosis. The influence of stent porosity on changing the local hemodynamics 
between the aneurysm and the parent vessel was shown in the experimental study [56]. 
4. Conclusion 
In conclusion, endovascular treatment of vertebral and carotid artery aneurysms with 
covered stents is very promising, safe and feasible treatment option. So called flow diverting 
devices despite their “slow mode” of action, but according to their special features (as is 
high flexibility and very low profile), seems to be very effective tool in endovascular 
treatment of carotid and vertebral artery aneurysms. On the other hand, covered stents with 
for example a novel pericardium covered stent, allow complete occlusion of the aneurysm, 
 
Aneurysm 264 
fistula or dissection in one action. This approach in the treatment of aneurysms seems to be 
very promising. Therapeutic decision making in the treatment of vertebral and carotid 
artery aneurysms must balance endovascular or surgical morbidity and mortality rates with 
the risk of hemorrhage and other considerations on an individual basis. Evolving 
technologies move towards increased covered stents flexibility with pushing down their 
profiles. This evolution followed with future studies of these advanced endovascular 
approaches will probably increase the role of covered stents in the field of endovascular 
treatment of vertebral and carotid artery aneurysms in the future. More detailed clinical 
studies will need to be conducted to confirm the overall performance and long-term effect of 
covered stents in the treatment of internal carotid and vertebral artery aneurysms. 
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